Judith Wolf, MD
Gynecologic Oncology · Green Bay, WINPI 1790878726
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AstraZeneca at 54.7% of the total. Reporting peaked in 2020 at $162 and has fallen 85.1% since, to $24 in 2025. That places this record below the midpoint for gynecologic oncology clinicians in WI, where the typical reported total is $699.
Across 13 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$170
- Sanofi$33
- Eisai Inc.$26
- Astellas Pharma US Inc$24
- Tesaro, Inc.$16
- Clovis Oncology, Inc.$16
- plus $26 from 2 others
What the payments were for
- Food & beverage$311100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $170 |
| Sanofi | 2 | $33 |
| Eisai Inc. | 2 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| Tesaro, Inc. | 1 | $16 |
| Clovis Oncology, Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$107
How this compares
$311 in reported general payments places this provider in the 35th percentile of 30 gynecologic oncology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Green Bay
- Elizabeth DubilGreen Bay$1K
- Louis DaintyGreen Bay$772
- Karuna MurrayGreen Bay$311
- Erin StevensGreen Bay$160
- Jennifer RhodeGreen Bay$22
- Nefertiti Dupontla Crosse$36K
- Paul TsengWauwatosa$10K
- Lisa BarroilhetMadison$9K
- Scott KamelleWest Allis$6K
- Irina DimitrovaMilwaukee$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.